Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche’s Highly Anticipated Ocrelizumab Delayed By Manufacturing Issues

Dec 20 2016

• By Jessica Merrill

Related Content

Roche’s Ocrelizumab Poised To Seize Primary Progressive MS Opportunity

Oct 08 2015

Manufacturing Problems Aren't Rising, But It Was A Hot July

Jul 30 2016

Roche's Ocrelizumab Strengthens Lead In Primary Progressive MS

Feb 17 2016

Related Companies

Roche Holding AG

Additional Topics

United States Manufacturing Drug Review Regulation Neurology BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window